Literature DB >> 9667386

Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector.

A I Brooks1, M W Halterman, C A Chadwick, B L Davidson, M Haak-Frendscho, C Radel, C Porter, H J Federoff.   

Abstract

To develop a reproducible gene transfer method for the murine CNS we evaluated delivery of various gene vehicles using mechanical or manual stereotaxic intracranial inoculation. A microprocessor controlled microsyringe pump (The World Precision Instruments/UltraMicroPump) programmable for volume, rate and syringe size and designed to dispense nanoliter and picoliter volumes was compared to a standard manual deliver method. Gene transfer efficiency of two viral vectors, two synthetic cationic lipid molecules, and naked DNA were evaluated in mice injected unilaterally in two brain regions. Animals received 1 microl over 10 min. of either HSVlac (1 x 10(5) b.f.u), AdLac (1 x 10(5) p.f.u), Tfx-10 or Tfx-20 (2.6 microg DNA in 2.0 microl Tfx; 1:1 charge ratio of DNA to liposome), or naked DNA (HSVlac plasmid, 10 microg/microl). After 4 days, animals from each group were perfused and tissue prepared for X-gal histochemical detection of beta-galactosidase expression. Blue cells were observed in the HSV, Adenovirus, and Tfx-20 groups only at the injection site in animals injected using the UMP. Animals injected manually exhibited fewer blue cells and positive cells were not restricted to the injection site. To quantify expression, tissue punches harvested from the injection sites as well as other brain regions were analyzed using a chemiluminescent reporter assay to detect beta-galactosidase (Galacto-Light). These data indicated increased activity in all animals injected with a lacZ containing vector via the UMP as compared to manual delivery: A 41% increase in the expression levels of beta-gal in HSVlac infected animals (p = 0.0029); a 29% increase in Adlac infected animals (p = 0.01); a 56% increase in Tfx-10 transduced animals (p = 0.04); a 24% increase in Tfx-20 transduced animals (p = 0.01); and a 69% increase in naked DNA gene transfer (p = 0.05). Total beta-galactosidase activity was greatest in HSVlac infected mice followed by Adlac > Tfx-20 > Tfx-10 = naked DNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667386     DOI: 10.1016/s0165-0270(97)00207-0

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  9 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain.

Authors:  Mihail Y Mastakov; Kristin Baer; C Wymond Symes; Claudia B Leichtlein; Robert M Kotin; Matthew J During
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Gene-experience interaction alters the cholinergic septohippocampal pathway of mice.

Authors:  A I Brooks; D A Cory-Slechta; H J Federoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

4.  Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain.

Authors:  Erin D Milligan; Ryan G Soderquist; Stephanie M Malone; John H Mahoney; Travis S Hughes; Stephen J Langer; Evan M Sloane; Steven F Maier; Leslie A Leinwand; Linda R Watkins; Melissa J Mahoney
Journal:  Neuron Glia Biol       Date:  2006-11

5.  In-tube transfection improves the efficiency of gene transfer in primary neuronal cultures.

Authors:  Marc W Halterman; Rita Giuliano; Chris Dejesus; Nina F Schor
Journal:  J Neurosci Methods       Date:  2008-10-30       Impact factor: 2.390

6.  Creating anatomically accurate and reproducible intracranial xenografts of human brain tumors.

Authors:  Angela M Pierce; Amy K Keating
Journal:  J Vis Exp       Date:  2014-09-24       Impact factor: 1.355

7.  Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.

Authors:  Costas G Hadjipanayis; Wendy Fellows-Mayle; Neal A Deluca
Journal:  Mol Ther       Date:  2008-08-26       Impact factor: 11.454

8.  Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells.

Authors:  Arvind Kumar; Tryambak D Singh; Santosh K Singh; Satya Prakash
Journal:  Biologics       Date:  2009-07-13

9.  Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity.

Authors:  Andre R Massensini; Harmanvir Ghuman; Lindsey T Saldin; Christopher J Medberry; Timothy J Keane; Francesca J Nicholls; Sachin S Velankar; Stephen F Badylak; Michel Modo
Journal:  Acta Biomater       Date:  2015-08-28       Impact factor: 10.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.